Form 4/A for VIR Vir Biotechnology, Inc.
Accepted 2022-05-10 00:00:00 ET · period of report 2021-12-20 · accession 0001062993-22-012007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-05-10 | 2021-12-20 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +102.0K | 247.5K | +70% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-20 | J | A | 102,041 | $0.00 | 247,546 | D | — | — | (F3) Correction made to include shares previously reported in prior filing on 5/21/21 but not included in the amount of shares beneficially owned in subsequent filings. |